Maharashtra FDA to Test Johnson & Johnson Baby Powder for Cancer-Causing Substances After $75 Million U.S Verdict

Published: Mar 10, 2016

The Maharashtra Food and Drug Administration (FDA) has slapped a notice on Johnson & Johnson (J&J) following a U.S. court's verdict that awarded $72 million to a 62-year-old woman's family after she died of cancer due to prolonged use of the company's talcum powder.

The FDA has collected samples of Shower to Shower, Dermicool, Ponds and Nycil talcum powder brands besides J&J from across Maharashtra and sent them to the laboratory to check if they follow the rules laid down under the Drug and Cosmetic Act.

The FDA said the test is important to determine the presence of heavy metals in the talcum powder, which may have carcinogenic properties.

Back to news